SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-027692
Filing Date
2023-05-05
Accepted
2023-05-05 16:38:21
Documents
1
Period of Report
2023-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4702
  Complete submission text file 0001209191-23-027692.txt   6249
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4747 EXECUTIVE DRIVE, SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE, SUITE 210 SAN DIEGO CA 92121 8582003830
Concentra Biosciences, LLC (Reporting) CIK: 0001970065 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37998 | Film No.: 23894519